Apoptotic Activity of Curcumin and EF-24 in HTB-41 Human Salivary Gland Epidermoid Carcinoma Cells
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Curcumin (diferuloylmethane), a constituent of turmeric powder derived from the rhizome of Curcuma longa, has been shown to inhibit the growth of various types of cancer cells by regulating cell proliferation and apoptosis. However, a need exists to design more effective analogs because of curcumin's poor intestinal absorption. EF-24 (diphenyl difluoroketone), the monoketone analog of curcumin, has shown good efficacy in anticancer screens. However, the effects of curcumin and EF-24 on salivary gland epidermoid carcinoma cells are not clearly established. The main goal of this study was to investigate the effects of curcumin and EF-24 on cell growth and induction of apoptosis in human salivary gland epidermoid carcinoma cells. Our studies showed that curcumin and EF-24 inhibited the growth of HTB-41 cells in a dose- and time-dependent manner, and the potency of EF-24 was > 34-fold that of curcumin. Treatment with curcumin or EF-24 resulted in nuclear condensation and fragmentation in HTB-41 cells, whereas the control HTB-41 cell nuclei retained their normal regular and oval shape. Curcumin and EF-24 promoted proteolytic cleavages of procaspase-3/-7/-9, resulting in an increase in the amount of cleaved caspase-3/-7/-9 in the HTB-41 cells. Caspase-3 and -7 activities were detected in viable HTB-41 cells treated with curcumin or EF-24. These results suggest that the curcumin and EF-24 inhibit cell proliferation and induce apoptosis in HTB-41 human salivary gland epidermoid carcinoma cells, and that they may have potential properties as an anti-cancer drug therapy.
Abstract
Curcumin (diferuloylmethane), a constituent of turmeric powder derived from the rhizome of Curcuma longa, has been shown to inhibit the growth of various types of cancer cells by regulating cell proliferation and apoptosis. However, a need exists to design more effective analogs because of curcumin's poor intestinal absorption. EF-24 (diphenyl difluoroketone), the monoketone analog of curcumin, has shown good efficacy in anticancer screens. However, the effects of curcumin and EF-24 on salivary gland epidermoid carcinoma cells are not clearly established. The main goal of this study was to investigate the effects of curcumin and EF-24 on cell growth and induction of apoptosis in human salivary gland epidermoid carcinoma cells. Our studies showed that curcumin and EF-24 inhibited the growth of HTB-41 cells in a dose- and time-dependent manner, and the potency of EF-24 was > 34-fold that of curcumin. Treatment with curcumin or EF-24 resulted in nuclear condensation and fragmentation in HTB-41 cells, whereas the control HTB-41 cell nuclei retained their normal regular and oval shape. Curcumin and EF-24 promoted proteolytic cleavages of procaspase-3/-7/-9, resulting in an increase in the amount of cleaved caspase-3/-7/-9 in the HTB-41 cells. Caspase-3 and -7 activities were detected in viable HTB-41 cells treated with curcumin or EF-24. These results suggest that the curcumin and EF-24 inhibit cell proliferation and induce apoptosis in HTB-41 human salivary gland epidermoid carcinoma cells, and that they may have potential properties as an anti-cancer drug therapy.
참고문헌 (40)
- PM Speight, "Salivary gland tumours", Oral Diseases, 8(5), pp.229~240 (2002), Wiley-Blackwell[DOI]
- Ellis GL, "Primary squamous cell carcinoma", pp.369~378 (1991), W. B. Saunders Company
- Yeung-Leung Cheng, "Anti-proliferative activity of Bupleurum scrozonerifolium in A549 human lung cancer cells in vitro and in vivo", Cancer Letters, 222(2), pp.183~193 (2005), Elsevier BV[DOI]
- Dong Il Park, "Induction of apoptosis and inhibition of telomerase activity by aqueous extract from Platycodon grandiflorum in human lung carcinoma cells", Pharmacological Research, 51(5), pp.437~443 (2005), Elsevier BV[DOI]
- M.L. Tan, "Methanolic extract of Pereskia bleo (Kunth) DC. (Cactaceae) induces apoptosis in breast carcinoma, T47-D cell line", Journal of Ethnopharmacology, 96(1-2), pp.287~294 (2005), Elsevier BV[DOI]
- Hoshino T, "Flow cytometric measurement of NK cell cytotoxicity", J Clin Lab Immunol, 36, pp.39~43 (1991)
- Ze Tian, "The cytotoxicity of naturally occurring styryl lactones", Phytomedicine, 13(3), pp.181~186 (2006), Elsevier BV[DOI]
- Smets LA, "Programmed cell death(apoptosis)and response to anti-cancer drugs", Anti-Cancer Drug, 5, pp.3~9 (1994)
- Adrian G Paschka, "Induction of apoptosis in prostate cancer cell lines by the green tea component, (−)-epigallocatechin-3-gallate", Cancer Letters, 130(1-2), pp.1~7 (1998), Elsevier BV[DOI]
- Green DR, "Mitochondria and Apoptosis", Science, 281(5381), pp.1309~1312 (1998), American Association for the Advancement of Science (AAAS)[DOI]
- Michael O. Hengartner, "The biochemistry of apoptosis", Nature, 407(6805), pp.770~776 (2000), Springer Nature[DOI]
- Scott H. Kaufmann, "Programmed cell death: alive and well in the new millennium", Trends in Cell Biology, 11(12), pp.526~534 (2001), Elsevier BV[DOI]
- Scott H. Kaufmann, "Induction of Apoptosis by Cancer Chemotherapy", Experimental Cell Research, 256(1), pp.42~49 (2000), Elsevier BV[DOI]
- John C Reed, "Apoptosis-regulating proteins as targets for drug discovery", Trends in Molecular Medicine, 7(7), pp.314~319 (2001), Elsevier BV[DOI]
- Mukhopadhyay A, "Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines", Oncogene, 20, pp.7597~7609 (2001)
- J Miquel, "The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review", Archives of Gerontology and Geriatrics, 34(1), pp.37~46 (2002), Elsevier BV[DOI]
- Banerjee M, "Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat", Immunopharmacol Immunotoxicol, 25, pp.213~224 (2003)
- R P Sahu, "Activation of ATM", Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells, 2009, pp.100(9), 1425~1433[DOI]
- Bharat B. Aggarwal, "RETRACTED: Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines", Biochemical Pharmacology, 73(7), pp.1024~1032 (2007), Elsevier BV[DOI]
- Beatrice Bachmeier, "The Chemopreventive Polyphenol Curcumin Prevents Hematogenous Breast Cancer Metastases in Immunodeficient Mice", Cellular Physiology and Biochemistry, 19(1-4), pp.137~152 (2007), S. Karger AG[DOI]
- Hauser PJ, "Sensitivity of bladder cancer cells to curcumin and its derivatives depends on the extracellular matrix", Anticancer Res, 27, pp.737~740 (2007)
- Sharmila Shankar, "Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase", AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer, 2007, ~[DOI]
- H WAHL, "Curcumin enhances Apo2L", TRAIL-induced apoptosis in chemoresistant ovarian cancer cells, 2007, pp.105(1), 104~112[DOI]
- Hermann Ammon, "Pharmacol Curcuma longa", Planta Medica, 57(01), pp.1~7 (1991), Thieme Publishing Group[DOI]
- Ajay Goel, "Curcumin as “Curecumin”: From kitchen to clinic", Biochemical Pharmacology, 75(4), pp.787~809 (2008), Elsevier BV[DOI]
- Preetha Anand, "Bioavailability of Curcumin: Problems and Promises", Molecular Pharmaceutics, 4(6), pp.807~818 (2007), American Chemical Society (ACS)[DOI]
- Brian K. Adams, "Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents", Bioorganic & Medicinal Chemistry, 12(14), pp.3871~3883 (2004), Elsevier BV[DOI]
- Adams BK, "EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redoxdependent mechanism", Anticancer Drugs, 16, pp.263~275 (2005)
- Myoung-Hwa Lee, "Ethanol Extracts of Angelica decursiva Induces Apoptosis in Human Oral Cancer Cells", International Journal of Oral Biology, 35(4), pp.215~220 (2010), 대한구강생물학회
- 신우철, "Growth Inhibition of Human Head and Neck Squamous Cell Carcinomas by Angelica decursiva Extracts", International Journal of Oral Biology, 35(4), pp.153~158 (2010), 대한구강생물학회
- Ji Young Kim, "Antioxidant Potential of Dimethyl Lithospermate Isolated from Salvia miltiorrhiza (Red Sage) Against Peroxynitrite", Journal of Medicinal Food, 11(1), pp.21~28 (2008), 한국식품영양과학회[DOI]
- Chun Sung Kim, "Inhibition of L-Type Amino Acid Transporter Modulates the Expression of Cell Cycle Regulatory Factors in KB Oral Cancer Cells", Biological & Pharmaceutical Bulletin, 33(7), pp.1117~1121 (2010), Pharmaceutical Society of Japan[DOI]
- Cohen GM, "Caspases : the executioners of apoptosis", Biochem J, 326, pp.1~16 (1997)
- R. Datta, "Caspase-3-mediated Cleavage of Protein Kinase C in Induction of Apoptosis", Journal of Biological Chemistry, 272(33), pp.20317~20320 (1997), American Society for Biochemistry & Molecular Biology (ASBMB)[DOI]
- Xuesong Liu, "DFF, a Heterodimeric Protein That Functions Downstream of Caspase-3 to Trigger DNA Fragmentation during Apoptosis", Cell, 89(2), pp.175~184 (1997), Elsevier BV[DOI]
- Wei Hu, "Anticancer therapy targeting the apoptotic pathway", The Lancet Oncology, 4(12), pp.721~729 (2003), Elsevier BV[DOI]
- Leonidas Christou, "Treatment of plasma cell leukemia with vincristine, liposomal doxorubicin and dexamethasone", European Journal of Haematology, 67(1), pp.51~53 (2001), Wiley-Blackwell[DOI]
- Ashis Mukherjee, "Advances in Cancer Therapy with Plant Based Natural Products", Current Medicinal Chemistry, 8(12), pp.1467~1486 (2001), Bentham Science Publishers Ltd.[DOI]
- John M. Pezzuto, "Plant-derived anticancer agents", Biochemical Pharmacology, 53(2), pp.121~133 (1997), Elsevier BV[DOI]
- Geert van Poppel, "Vitamins and cancer", Cancer Letters, 114(1-2), pp.195~202 (1997), Elsevier BV[DOI]
